loading
Schlusskurs vom Vortag:
$2.60
Offen:
$2.61
24-Stunden-Volumen:
259.64K
Relative Volume:
0.19
Marktkapitalisierung:
$347.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.44M
KGV:
-7.5714
EPS:
-0.35
Netto-Cashflow:
$-42.28M
1W Leistung:
+9.38%
1M Leistung:
+24.41%
6M Leistung:
+79.79%
1J Leistung:
+118.75%
1-Tages-Spanne:
Value
$2.54
$2.66
1-Wochen-Bereich:
Value
$2.32
$2.76
52-Wochen-Spanne:
Value
$0.765
$4.08

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
Firmenname
Compass Therapeutics Inc
Name
Telefon
617-500-8099
Name
Adresse
80 GUEST STREET, BOSTON
Name
Mitarbeiter
35
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CMPX's Discussions on Twitter

Vergleichen Sie CMPX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CMPX
Compass Therapeutics Inc
2.66 347.09M 0 -45.44M -42.28M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.51 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
530.50 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
318.00 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
564.29 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.75 28.51B 3.81B -644.79M -669.77M -6.24

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-02 Hochstufung Leerink Partners Market Perform → Outperform
2025-02-24 Eingeleitet Guggenheim Buy
2025-02-19 Eingeleitet Piper Sandler Overweight
2024-12-23 Eingeleitet D. Boral Capital Buy
2024-11-15 Herabstufung Leerink Partners Outperform → Market Perform
2024-09-16 Hochstufung Ladenburg Thalmann Neutral → Buy
2023-01-31 Eingeleitet Jefferies Buy
2023-01-27 Eingeleitet Stifel Buy
2022-05-23 Fortgesetzt H.C. Wainwright Buy
2022-03-15 Eingeleitet Ladenburg Thalmann Buy
2022-01-19 Eingeleitet B. Riley Securities Buy
2021-12-22 Eingeleitet Raymond James Outperform
2021-12-20 Eingeleitet SVB Leerink Outperform
2021-12-15 Eingeleitet Wedbush Outperform
Alle ansehen

Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten

pulisher
Jun 17, 2025

PD-1 and PD-L1 Inhibitors Competitor Landscape Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Compass Therapeutics, Aurigene Discovery Tech - The Globe and Mail

Jun 17, 2025
pulisher
Jun 16, 2025

SG Americas Securities LLC Buys 545,767 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Acquired by Bank of America Corp DE - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLC - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 48,021 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Compass Therapeutics Confirms Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Cholangiocarcinoma Market Booming Worldwide, Estimated to Reach USD 2,334.4 Mn by 2032 | Incyte CorporationSOUTHEAST - SOUTHEAST - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 12, 2025

Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist - Yahoo Finance

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Acquires New Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

CMPX to Participate in Virtual Meeting Hosted by Piper Sandler | - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

CMPX to Participate in Virtual Meeting Hosted by Piper Sandler | CMPX Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Cuts Stake in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Transition Metals (CVE:XTM) Shares Up 62.5% – Time to Buy? - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Purchased by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Makes New $27,000 Investment in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Has $42,000 Position in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 05, 2025
pulisher
May 29, 2025

Northern Trust Corp Sells 43,164 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 29, 2025
pulisher
May 29, 2025

Compass Therapeutics, Inc. (CMPX) Stock Analysis: A Biotech Gem with Over 500% Potential Upside - DirectorsTalk Interviews

May 29, 2025
pulisher
May 28, 2025

Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire

May 28, 2025
pulisher
May 27, 2025

Insider Buying: Thomas Schuetz Acquires Additional Shares of Com - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO acquires $21,100 in common stock - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO acquires $21,100 in common stock By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO Acquires 10,000 Shares - TradingView

May 27, 2025
pulisher
May 22, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Rating of “Buy” from Brokerages - Defense World

May 22, 2025
pulisher
May 19, 2025

Dimensional Fund Advisors LP Buys New Stake in Babcock & Wilcox Enterprises, Inc. (NYSE:BW) - Defense World

May 19, 2025
pulisher
May 19, 2025

Bell Investment Advisors Inc Buys 79 Shares of Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Dark Forest Capital Management LP Cuts Stock Holdings in NVIDIA Co. (NASDAQ:NVDA) - Defense World

May 19, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Increases Holdings in Absci Co. (NASDAQ:ABSI) - Defense World

May 19, 2025
pulisher
May 19, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Bought by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 19, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 19, 2025

Ceera Investments LLC Grows Stock Position in Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Apple Inc. (NASDAQ:AAPL) is Sound View Wealth Advisors Group LLC’s Largest Position - Defense World

May 19, 2025
pulisher
May 19, 2025

Frontier Asset Management LLC Acquires 1,041 Shares of Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Rebalance LLC Grows Stake in Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Ocugen, Inc. (NASDAQ:OCGN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 16, 2025

Voya Investment Management LLC Sells 5,102 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 16, 2025
pulisher
May 14, 2025

Spotlight On Three Promising Penny Stocks In May 2025 - Yahoo Finance

May 14, 2025
pulisher
May 13, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Acquired by Wells Fargo & Company MN - Defense World

May 13, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Acquires 13,038 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 13, 2025
pulisher
May 12, 2025

Compass Therapeutics: A Big Positive Signal For Tovecimig In Biliary Tract Cancers - Seeking Alpha

May 12, 2025
pulisher
May 12, 2025

Guggenheim Cuts Compass Therapeutics (NASDAQ:CMPX) Price Target to $10.00 - Defense World

May 12, 2025
pulisher
May 12, 2025

Barclays PLC Has $279,000 Stock Position in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 12, 2025
pulisher
May 10, 2025

Mariner LLC Purchases New Stake in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 10, 2025
pulisher
May 09, 2025

Guggenheim Adjusts Price Target for Compass Therapeutics (CMPX) - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics (CMPX) Price Target Lowered by Guggenheim | CMPX Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

Compass Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 06, 2025

Compass Therapeutics to Participate in Upcoming May Investor Events - GlobeNewswire

May 06, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Grows Stock Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 05, 2025
pulisher
May 05, 2025

Cholangiocarcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - Barchart.com

May 05, 2025

Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Compass Therapeutics Inc-Aktie (CMPX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
GORDON CARL L
Director
Apr 09 '25
Sale
1.59
3,571,428
5,678,571
0
ORBIMED ADVISORS LLC
Director
Apr 09 '25
Sale
1.59
3,571,428
5,678,571
0
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
Kapitalisierung:     |  Volumen (24h):